Re:Scientists discover a highly potent antibody against SARS...
by johncolanduoni on Thursday October 14, 2021 @02:38PM
(#28868163)
> The technology to make monoclonal antibodies is simpler than that for mRNA vaccines.
It’s more mature technology, but unlike the mRNA vaccines it’s not cell free and as a result is harder to scale up. At similar scale mRNA will still be cheaper; that’s one if mRNA’s biggest selling points.
It’s more mature technology, but unlike the mRNA vaccines it’s not cell free and as a result is harder to scale up. At similar scale mRNA will still be cheaper; that’s one if mRNA’s biggest selling points.